Large gap with delayed quotes
|
Last quote
11/04/2025
-
02:00:00
|
Bid
11/04/2025 -
13:01:14
|
Bid Volume |
Ask
11/04/2025 -
13:01:14
|
Ask Volume |
|---|---|---|---|---|
|
22.19
+0.81
(
+3.79% )
|
15.11
|
100 |
25.72
|
100 |
Analysis date: 31.10.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 31.10.2025.
Interest
Weak
Weak
Two stars since 07.10.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 07.10.2025 at a price of 23.62.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 03.10.2025.
4wk Rel Perf
-19.30%
-19.30%
The four-week dividend-adjusted underperformance versus SP500 is 19.30%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.98%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.82%.
Mkt Cap in $bn
0.96
0.96
With a market capitalization <$2bn, PACIRA BIOSCIENCES is considered a small-cap stock.
G/PE Ratio
1.59
1.59
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
5.27
5.27
The estimated PE is for the year 2028.
LT Growth
8.38%
8.38%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
12
12
For 1% of index variation, the stock varies on average by 0.12%.
Correlation
0.05
0.05
Stock movements are totally independent of index variations.
Value at Risk
5.13
5.13
The value at risk is estimated at USD 5.13. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
19.09.2014
19.09.2014